A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer
AD Elias(Beth Israel Deaconess Medical Center), Lois Ayash(Wayne State University), Paul G. Richardson(Harvard University), E Reich(Harvard University), David Avigan(Beth Israel Deaconess Medical Center), George D. Demetri(Dana-Farber Cancer Institute), Joseph G. Ibrahim(University of North Carolina at Chapel Hill), Catherine Wheeler(Harvard University), D Warren(Beth Israel Deaconess Medical Center), Emil Frei(Dana-Farber Cancer Institute), Robin Joyce(Beth Israel Deaconess Medical Center), J Levine, Timothy D. Arthur(Broad Institute)
Cited by 14
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k